Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Poorni Manohar"'
Autor:
Poorni Manohar, Hannah Linden, Veena Shankaran, Catherine Fedorenko, Jenna Voutsinas, Qin Sun, Vicky Wu
Publikováno v:
Cancer Research. 83:P4-07
Background: Evidence-based recommendations for the management of metastatic breast cancer (MBC) endorse confirmation of recurrence with biopsy and reassessment of biomarker status. National guidelines support numerous treatment options and do not cap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a61864734e4422ae3b8b8e694769b444
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-47
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-47
Autor:
Poorni Manohar, Nancy E. Davidson
Publikováno v:
Cancer Biology & Medicine, Vol 19, Iss 2, Pp 202-212 (2022)
Endocrine therapy (ET) remains the mainstay of treatment for steroid hormone receptor-positive, human epidermal growth factor 2 (HER2)-negative metastatic breast cancer (MBC). Tumor resistance to hormone therapy has led to the development of novel en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13291c31d5601a517fca869137f7a2d9
http://www.cancerbiomed.org/index.php/cocr/article/view/1953
http://www.cancerbiomed.org/index.php/cocr/article/view/1953
Publikováno v:
Journal of Clinical Pathways. 9
We assessed bone-modifying agent (BMA) utilization and cost in patients with metastatic cancer and bone involvement at a National Cancer Institute–designated cancer center. We performed a retrospective review of BMA (zoledronic acid [ZA] or denosum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f0a1ef9b30eedd552c5642179dae5d0
https://doi.org/10.25270/jcp.2023.03.01
https://doi.org/10.25270/jcp.2023.03.01
Autor:
David A. Mankoff, Paul E. Kinahan, Kenneth A. Krohn, Jeanne M. Link, Poorni Manohar, Lanell M. Peterson, Mark Muzi, Isaac C. Jenkins, Hannah M. Linden, Vicky Wu, Jennifer M. Specht, Delphine L. Chen
Publikováno v:
Cancer Research. 81:PD6-10
Background: The histology and pattern of spread in lobular breast cancer has presented challenges in estimating extent of disease by traditional imaging methods. 18F-FES is an estrogen analogue PET imaging tracer which measures tumor ER expression at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86ca591f6379b05221ced60d2f79c428
https://doi.org/10.1158/1538-7445.sabcs20-pd6-10
https://doi.org/10.1158/1538-7445.sabcs20-pd6-10
Autor:
Tomoko Sugihara, Lisa M. Hess, Hannah M. Linden, Lee D. Cranmer, Poorni Manohar, Yajun E Zhu, Howard G Muntz
Publikováno v:
Cancer Research. 81:PS13-38
Background While novel targeted agents are increasingly used to care for patients with breast cancer, doxorubicin (DOX) continues to play a role in management of patients, particularly those with aggressive disease. Dose-dependent cardiomyopathy is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::775c16b0df4ee04fea2b29c93d66e678
https://doi.org/10.1158/1538-7445.sabcs20-ps13-38
https://doi.org/10.1158/1538-7445.sabcs20-ps13-38
Publikováno v:
Cancer Research. 80:P6-13
Background: Potential discordance in estrogen receptor (ER) status between primary and metastatic breast cancer (mBC) site mandates the need for accurate diagnosis. Biopsy is not performed routinely due to inaccessible sites. Additionally, interpreta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b955d5a9659e34feb7f355b289a0bc6e
https://doi.org/10.1158/1538-7445.sabcs19-p6-13-03
https://doi.org/10.1158/1538-7445.sabcs19-p6-13-03
Publikováno v:
Journal of the American College of Radiology. 17:137-140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6915c485a3b98288af43de493f5a08c
https://doi.org/10.1016/j.jacr.2019.07.030
https://doi.org/10.1016/j.jacr.2019.07.030
Autor:
KA Krohn, David A. Mankoff, Lanell M. Peterson, Alena Novakova-Jiresova, Isaac C. Jenkins, Poorni Manohar, Paul E. Kinahan, JM Link, Hannah M. Linden, Vicky Wu, Jennifer M. Specht
Publikováno v:
Cancer Research. 79:PD4-10
Background: The histology and pattern of spread in lobular breast cancer has presented challenges in estimating extent of disease and identifying treatment options. 18F-FES is an estrogen analogue PET imaging tracer which measures tumor ER expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::308fd422dc66c61aa0972469e70e9360
https://doi.org/10.1158/1538-7445.sabcs18-pd4-10
https://doi.org/10.1158/1538-7445.sabcs18-pd4-10
Autor:
Poorni Manohar, Catherine R. Fedorenko, Qin Sun, Jenna M. Voutsinas, Vicky Wu, Josh Roth, Hannah M. Linden, Veena Shankaran
Publikováno v:
Journal of Clinical Oncology. 40:e13640-e13640
e13640 Background: Evidence-based, national guidelines for the diagnosis of recurrent metastatic breast cancer (MBC) recommend confirmation of recurrence with biopsy and reassessment of biomarker status. Real world practice patterns may demonstrate d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5515a1bc9c88a69f185608caecf8913f
https://doi.org/10.1200/jco.2022.40.16_suppl.e13640
https://doi.org/10.1200/jco.2022.40.16_suppl.e13640
Publikováno v:
Thromb Res
Introduction While trials have demonstrated non-inferiority of direct oral anticoagulant drugs (DOAC) to low-molecular-weight heparins (LMWH) for the treatment of cancer associated thrombosis (CAT), it is unclear if the newer intervention is cost-eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d7ba45431c54731d7160220ba37ea05
https://pubmed.ncbi.nlm.nih.gov/31200341
https://pubmed.ncbi.nlm.nih.gov/31200341